BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2835943)

  • 61. Intraperitoneal metastases after transarterial embolization of hepatocellular carcinoma: An observational study.
    Meier JM; Behr SC; Jordan E; Pallav Kolli K; Yeh BM
    Abdom Radiol (NY); 2017 Jun; 42(6):1794-1798. PubMed ID: 28197682
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Hepatic resection for hepatocellular carcinoma--results and analysis of the current literature].
    Neeff H; Makowiec F; Harder J; Gumpp V; Klock A; Thimme R; Drognitz O; Hopt UT
    Zentralbl Chir; 2009 Apr; 134(2):127-35. PubMed ID: 19382043
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Preoperative assessment of hepatocellular carcinoma tumor grade using needle biopsy: implications for transplant eligibility.
    Pawlik TM; Gleisner AL; Anders RA; Assumpcao L; Maley W; Choti MA
    Ann Surg; 2007 Mar; 245(3):435-42. PubMed ID: 17435551
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A 5-year survivor after resection of peritoneal metastases from pedunculated-type hepatocellular carcinoma.
    Kurachi K; Suzuki S; Yokoi Y; Okumura T; Inaba K; Igarashi T; Takehara Y; Konno H; Baba S; Nakamura S
    J Gastroenterol; 2002; 37(7):571-4. PubMed ID: 12162418
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The Singapore Liver Cancer Recurrence (SLICER) Score for relapse prediction in patients with surgically resected hepatocellular carcinoma.
    Ang SF; Ng ES; Li H; Ong YH; Choo SP; Ngeow J; Toh HC; Lim KH; Yap HY; Tan CK; Ooi LL; Cheow PC; Chung AY; Chow PK; Foo KF; Tan MH
    PLoS One; 2015; 10(4):e0118658. PubMed ID: 25830231
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Liver resection for hepatocellular carcinoma in cirrhotic patients].
    Târcoveanu E; Lupaşcu C; Georgescu S; Zugun F; Crumpei F; Epure O; Nicorici C; Canschi G; Ferariu D
    Rev Med Chir Soc Med Nat Iasi; 2005; 109(4):770-80. PubMed ID: 16610175
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].
    Tischoff I; Tannapfel A
    Zentralbl Chir; 2007 Aug; 132(4):300-5. PubMed ID: 17724632
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [A clinical study of liver resections in patients with small hepatocellular carcinoma less than three centimeter in diameter].
    Nakajima Y; Nagabuchi E; Sato N; Kamiyama T; Matsuoka S; Une Y; Uchino J
    Nihon Geka Gakkai Zasshi; 1992 Sep; 93(9):1087-90. PubMed ID: 1335111
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Phase 2 study of stereotactic body radiotherapy and optional transarterial chemoembolization for solitary hepatocellular carcinoma not amenable to resection and radiofrequency ablation.
    Takeda A; Sanuki N; Tsurugai Y; Iwabuchi S; Matsunaga K; Ebinuma H; Imajo K; Aoki Y; Saito H; Kunieda E
    Cancer; 2016 Jul; 122(13):2041-9. PubMed ID: 27062278
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Treatment of hepatic recurrence after resection of hepatocellular carcinomas].
    Sbaï Idrissi MS; Vons C; Borgonovo G; Mariette D; Smadja C; Franco D
    Ann Chir; 1998; 52(6):543-6. PubMed ID: 9752504
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Solitary large hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma with good outcome after hepatic resection.
    Yang LY; Fang F; Ou DP; Wu W; Zeng ZJ; Wu F
    Ann Surg; 2009 Jan; 249(1):118-23. PubMed ID: 19106686
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Scirrhous hepatocellular carcinoma: comparison with usual hepatocellular carcinoma based on CT-pathologic features and long-term results after curative resection.
    Kim SH; Lim HK; Lee WJ; Choi D; Park CK
    Eur J Radiol; 2009 Jan; 69(1):123-30. PubMed ID: 17976942
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Uterine metastasis from hepatocellular carcinoma: A case report.
    Ryo E; Sato T; Takeshita S; Ayabe T; Tanaka F
    Int J Gynecol Cancer; 2006; 16(5):1894-6. PubMed ID: 17009988
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hepatocellular carcinoma of the intrabiliary growth type.
    Ikeda Y; Matsumata T; Adachi E; Hayashi H; Takenaka K; Sugimachi K
    Int Surg; 1997; 82(1):76-8. PubMed ID: 9189809
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Efficacy of major hepatic resection for large hepatocellular carcinoma.
    Shuto T; Hirohashi K; Kubo S; Tanaka H; Yamamoto T; Ikebe T; Kinoshita H
    Hepatogastroenterology; 1999; 46(25):413-6. PubMed ID: 10228832
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Current status of surgical treatment for hepatocellular carcinoma.
    Yogita S; Tashiro S
    J Med Invest; 2000 Aug; 47(3-4):91-100. PubMed ID: 11019487
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pedunculated hepatoma.
    Shah KH; Joshi AS; Relekar RG; Bapat RD
    Indian J Gastroenterol; 1992 Jan; 11(1):42-3. PubMed ID: 1312996
    [No Abstract]   [Full Text] [Related]  

  • 78. [A case report of pedunculated hepatocellular carcinoma, and review of case report in the literature].
    Eriguchi N; Nonaka M; Yakabe S; Ikejiri K; Kusumoto T; Emi Y; Saku M; Yoshida K
    Nihon Shokakibyo Gakkai Zasshi; 1997 Jul; 94(7):503-7. PubMed ID: 9277116
    [No Abstract]   [Full Text] [Related]  

  • 79. Blood supply characteristics of pedunculated hepatocellular carcinoma prior to and following transcatheter arterial chemoembolization treatment: An angiographic demonstration.
    Huang D; Chen Y; Zeng Q; Zhao J; Wu X; Wu R; Li Y
    Oncol Lett; 2018 Mar; 15(3):3383-3389. PubMed ID: 29599845
    [TBL] [Abstract][Full Text] [Related]  

  • 80. TACE plus percutaneous chemotherapy-lipiodol treatment of unresectable pedunculated hepatocellular carcinoma.
    Huang D; Chen Y; Chen S; Zeng Q; Zhao J; Wu R; Li Y
    Medicine (Baltimore); 2017 Jul; 96(30):e7650. PubMed ID: 28746230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.